Height and impaired glucose tolerance, hypertension, and coronary heart disease The San Luis Valley Diabetes Study
Hamman, R.F.; Shetterly, S.M.; Rewers, M.; Marshall, J.A.; Baxter, J.
American Journal of Epidemiology 136(8): 972
1992
ISSN/ISBN: 0002-9262
Accession: 031659485
PDF emailed within 1 workday: $29.90
Related References
Rewers, M.; Shetterly, S.M.; Baxter, J.; Marshall, J.A.; Hamman, R.F. 1992: Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population. the San Luis Valley Diabetes Study American Journal of Epidemiology 135(12): 1321-1330Fulton Kehoe, D.L.; Baxter, J.; Hamman, R.F. 1992: Excess prevalence of gallbladder disease among Hispanic and non-Hispanic white persons with impaired glucose tolerance The San Luis Valley diabetes study American Journal of Epidemiology 136(8): 1016
Burchfiel, C.M.; Hamman, R.F.; Marshall, J.A.; Baxter, J.; Kahn, L.B.; Amirani, J.J. 1990: Cardiovascular risk factors and impaired glucose tolerance: the San Luis Valley Diabetes Study American Journal of Epidemiology 131(1): 57-70
Marshall, J.A.; Hoag, S.; Shetterly, S.; Hamman, R.F. 1994: Dietary fat predicts conversion from impaired glucose tolerance to NIDDM. The San Luis Valley Diabetes Study Diabetes Care 17(1): 50-56
Regensteiner, J.G.; Shetterly, S.M.; Mayer, E.J.; Eckel, R.H.; Haskell, W.L.; Baxter, J.; Hamman, R.F. 1995: Relationship between habitual physical activity and insulin area among individuals with impaired glucose tolerance. The San Luis Valley Diabetes Study Diabetes Care 18(4): 490-497
Burchfiel, C.M.; Shetterly, S.M.; Baxter, J.; Hamman, R.F. 1992: The roles of insulin, obesity, and fat distribution in the elevation of cardiovascular risk factors in impaired glucose tolerance. The San Luis Valley Diabetes Study American Journal of Epidemiology 136(9): 1101-1109
Kim, S.H.; Chunawala, L.; Linde, R.; Reaven, G.M. 2006: Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice Journal of the American College of Cardiology 48(2): 293-297
Wei, Y.; Xu, W. 2019: Effect of acarbose on cardiovascular events and new-onset diabetes in patients with coronary heart disease and impaired glucose tolerance Future Cardiology 15(2): 127-133
Pan, X.R.; Hu, Y.H.; Li, G.W.; Liu, P.A.; Bennett, P.H.; Howard, B.V. 1993: Impaired glucose tolerance and its relationship to ECG-indicated coronary heart disease and risk factors among Chinese. Da Qing IGT and diabetes study Diabetes Care 16(1): 150-156
Fontbonne, A.; Eschwege, E.; Cambien, F.; Richard, J.L.; Ducimetiere, P.; Thibult, N.; Warnet, J.M.; Claude, J.R.; Rosselin, G.E. 1988: Patients with impaired glucose tolerance or diabetes in the paris prospective study hypertriglyceridemia is a risk factor of coronary heart disease mortality Diabetes Research and Clinical Practice 5(Suppl 1): S37
Blake, D.R.; Meigs, J.B.; Muller, D.C.; Najjar, S.S.; Andres, R.; Nathan, D.M. 2004: Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging Diabetes 53(8): 2095-2100
Qiao, Q.; Jousilahti, P.; Eriksson, J.; Hu, G.; Toumilehto, J. 2003: Predictive properties of isolated impaired glucose tolerance for incident coronary heart disease and cardiovascular mortality are not explained by the development of diabetes during the follow-up Diabetologia 46(Suppl 2): A143
Fontbonne, A.; Thibult, N.; Eschwège, E.; Ducimetière, P. 1992: Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: the Paris Prospective Study, 15-year follow-up Diabetologia 35(5): 464-468
Holman, R.R.; Coleman, R.L.; Chan, J.C.N.; Chiasson, J.-L.; Feng, H.; Ge, J.; Gerstein, H.C.; Gray, R.; Huo, Y.; Lang, Z.; McMurray, J.J.; Rydén, L.; Schröder, S.; Sun, Y.; Theodorakis, M.J.; Tendera, M.; Tucker, L.; Tuomilehto, J.; Wei, Y.; Yang, W.; Wang, D.; Hu, D.; Pan, C.; Keenan, J.; Milton, J.; Doran, Z.; Bray, C.; Rouleau, J.L.; Collier, J.; Pocock, S.; Standl, E.; Swedberg, K.; Weng, J.; Zhao, D.; Petrie, M.C.; Connolly, E.; Jhund, P.; MacDonald, M.; Myles, R.C.; Bai, R.; Li, J.; Liu, Z.; Liu, Z.; Peng, D.; Tong, Q.; Wang, C.; Yan, X.; Zhang, Y.; Zhou, J.; Sattar, N.; Fisher, M.; Petrie, J.R.; Bethel, M.A.; Xu, W.; Hearn, S.; Kappai, A.; Su, S.-Y.; Liyanage, W.; Paul, S.; Pozzi, E.; Ring, A.; Athwal, R.; Batra, P.; Ferch, A.; Gro 2017: Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial LANCET. Diabetes and Endocrinology 5(11): 877-886
Fontbonne, A.; Eschwège, E.; Cambien, F.; Richard, J.L.; Ducimetière, P.; Thibult, N.; Warnet, J.M.; Claude, J.R.; Rosselin, G.E. 1989: Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study Diabetologia 32(5): 300-304